Introduction
============

Mitochondria are highly dynamic organelles that continuously fuse and divide within cells ([@bib37]; [@bib54]; [@bib60]; [@bib81]; [@bib5]; [@bib14]; [@bib48]; [@bib12]; [@bib31]). A balance between mitochondrial fusion and division is critical for the maintenance of normal mitochondrial structures and cellular physiology. For example, defects in mitochondrial fusion typically result in mitochondrial fragmentation as a result of excessive division. However, defects in mitochondrial division produce highly connected mitochondrial tubules as a result of excessive mitochondrial fusion. The importance of a balance between fusion and division in the regulation of organelle morphogenesis is highlighted by the observations that mitochondria lacking both fusion and division functions have wild-type morphology ([@bib63]).

Normal mitochondrial dynamics are critical for human health and disease ([@bib39]; [@bib80]). Mitochondrial fusion defects cause human neuropathies, including autosomal dominant optic atrophy and Charcot-Marie-Tooth disease type 2A ([@bib4]; [@bib21]; [@bib76]). Abnormalities in division have also been implicated in Charcot-Marie-Tooth type 4A, Parkinson\'s disease, Alzheimer\'s disease, and abnormal brain development ([@bib19]; [@bib71]; [@bib22]; [@bib59]; [@bib73]; [@bib18]). The neurodegeneration associated with these diseases suggests that neuronal function and survival depend on mitochondrial fusion and division, possibly due to a high demand for ATP and specialized cellular morphologies ([@bib39]).

A dynamin-related GTPase, Dnm1p (yeast)/Drp1 (mammals), functions in mitochondrial division ([@bib8]; [@bib43]; [@bib63]; [@bib65]) and distribution ([@bib55]; [@bib13]). Studies have suggested that Dnm1p/Drp1 self-assembles into spirals that wrap around mitochondria and pinches off their membranes as a mechanochemical enzyme ([@bib74]; [@bib32]). Alternatively, Dnm1p/Drp1 may function as a classical regulatory GTPase ([@bib26]). Most Drp1 is cytosolic and is recruited to the surface of mitochondria by proteins such as Fis1p/Fis1, Mdv1p, Caf4p, and Num1p ([@bib49]; [@bib68]; [@bib11]; [@bib36]; [@bib75]: [@bib29]; [@bib13]). The association of Drp1 with mitochondria and its activity are regulated by phosphorylation, ubiquitination, and sumoylation ([@bib61]). Drp1 is also involved in peroxisome division, indicating that a common mechanism exists for mitochondrial and peroxisomal division ([@bib46]; [@bib41]; [@bib40]). In addition, previous studies have shown that Drp1 regulates apoptosis; however, its exact role in apoptosis remains to be determined ([@bib25]; [@bib27]; [@bib34]; [@bib57]; [@bib1]; [@bib28]; [@bib9]; [@bib10]; [@bib35]; [@bib67]). The RNAi knockdown of Drp1 was examined in *Caenorhabditis elegans* and revealed an important role in embryonic development ([@bib43]). However, the physiological role of Drp1 in mitochondrial division has not been studied in mammals. In this study, we describe for the first time the characterization of complete and brain-specific Drp1 knockout mice. Our data demonstrate the physiological importance of Drp1-mediated organelle division for embryonic development, brain development, mitochondrial morphogenesis, and developmentally regulated apoptosis.

Results and discussion
======================

Drp1 deletion causes embryonic lethality in mice
------------------------------------------------

To investigate the in vivo function of Drp1, we generated complete and conditional mouse knockouts as described in Materials and methods ([Fig. 1](#fig1){ref-type="fig"}). To examine the effect of complete loss of Drp1, we analyzed the genotype of 244 progeny from crosses of heterozygous mice. *Drp1*^+/−^ heterozygous mice express a partially reduced level of Drp1 (∼75% of wild-type level; [Fig. S1](http://www.jcb.org/cgi/content/full/jcb.200903065/DC1)) and are viable, fertile, normal in size, and do not display any gross physical or behavioral abnormalities. None of the progeny were homozygous for deletion of Drp1 ([Fig. 1 C](#fig1){ref-type="fig"}). These results suggest that homozygous deletion of Drp1 leads to embryonic lethality. To determine how loss of Drp1 affects embryonic development, we dissected embryos of various stages from pregnant female mice after timed breeding. We found *Drp1^−/−^* embryos at approximately expected frequencies between embryonic days (E) 9.5 and 11.5 ([Fig. 1 D](#fig1){ref-type="fig"}). However, the viability of embryos, as determined by the presence of a beating heart, was compromised in *Drp1^−/−^* embryos. At E11.5, we found no viable *Drp1^−/−^* embryos, and most showed internal hemorrhage ([Fig. 1 F](#fig1){ref-type="fig"}). In addition, *Drp1^−/−^* embryos appeared smaller than littermate *Drp1*^+/+^ and *Drp1*^+/−^ embryos, suggesting a developmental delay ([Fig. 1, F and G](#fig1){ref-type="fig"}). Loss of Drp1 expression was confirmed in whole embryos by immunoblotting ([Fig. 1 E](#fig1){ref-type="fig"}). Thus, Drp1 is essential for embryonic development in mice.

![**Drp1 is required for embryonic mouse development.** (A) Design of Drp1 knockout alleles. WT, wild type. (B) Confirmation of knockout by PCR. Genomic DNAs were prepared from embryos, yolk sack, or tails of adult mice for PCR. To distinguish *Drp1^+/+^*, *Drp1^+/−^*, and *Drp1^−/−^*, D1, D3, and D5 were used. Wild-type and null alleles produced 315-bp and 539-bp PCR products, respectively. For floxed alleles, D3 and D6 were used. Wild-type (+) and floxed (F) alleles generated 355-bp and 532-bp PCR products, respectively. (C) Genotypes of offspring from breeding of *Drp1^+/−^* mice. (D) Number of viable embryos. (E) Immunoblotting of embryos. (F) Images of embryos. (G) Crown rump length of embryos. \*\*\*, P \< 0.001 (*n* ≥ 14).](JCB_200903065_RGB_Fig1){#fig1}

*Drp1^−/−^* embryos are defective in placental development and show decreased cardiomyocyte beat rates
------------------------------------------------------------------------------------------------------

To determine the causes of embryonic lethality at E11.5, we examined the placenta, heart, and angiogenesis, which are important for embryo survival at this developmental stage. Strikingly, E10.5 *Drp1^−/−^* embryos lacked the trophoblast giant cell layer in the placenta as shown by DAPI staining ([Fig. 2 A](#fig2){ref-type="fig"}). To confirm that this was not simply caused by developmental delays, we also examined E9.5 *Drp1*^+/+^ embryos, which were size matched to the E10.5 *Drp1^−/−^* embryos, and observed trophoblast giant cell layers. These results clearly show that Drp1 is required for placental development and suggest that a defective exchange of nutrients and oxygen between the mother and fetus is likely involved in the embryonic lethality of *Drp1^−/−^* mice. Also, the heart was clearly beating in E9.5--10.5 *Drp1^−/−^* embryos, and in histological analysis of serial sagittal sections, the architecture of the heart appeared normal ([Fig. 2 B](#fig2){ref-type="fig"}). However, cardiomyocytes isolated from E10.5 *Drp1^−/−^* embryos had decreased beating rates relative to those isolated from E9.5 and 10.5 *Drp1*^+/+^ embryos ([Fig. 2 C](#fig2){ref-type="fig"}). This suggests that heart defects also contribute to the lethality of *Drp1^−/−^* embryos. Finally, we examined angiogenesis in whole embryos by immunohistochemistry using antibodies to PECAM and found indistinguishable patterns of blood vessels in *Drp1*^+/+^ and *Drp1^−/−^* embryos ([Fig. 2 D](#fig2){ref-type="fig"}).

![**Characterization of *Drp1^−/−^* embryos.** (A) DAPI-stained sections of placenta of age-matched E10.5 *Drp1^+/+^* and *Drp1^−/−^* embryos and an E9.5 *Drp1^+/+^* embryo, which was size matched to the E10.5 *Drp1^−/−^* embryos. Insets show enlarged images of boxed regions. Trophoblast giant cell (TGC) and labyrinth (L) layers are indicated. (B) H&E stains of sagittal sections of embryonic heart. (C) Beat rates in isolated embryonic cardiomyocytes were measured using differential interference contrast microscopy. (D) Whole-mount immunohistochemistry of embryos with anti-PECAM antibodies. \*\*, P \< 0.01 (*n* ≥ 39). Error bars indicate mean ± SEM.](JCB_200903065_RGB_Fig2){#fig2}

The timing of *Drp1^−/−^* embryonic lethality is similar to the timing of lethality in mice defective in Mfn1, Mfn2, and Opa1, which are all necessary for mitochondrial fusion ([@bib15]; [@bib3]; [@bib20]). This suggests that proper mitochondrial dynamics are critical for embryonic development in mice. For example, like Drp1-null mice, Mfn2-null mice lack trophoblast giant cell layers ([@bib15]). Although Drp1 controls the division of mitochondria and peroxisomes, it is likely that the embryonic lethality of *Drp1^−/−^* mice results from defects in mitochondrial division rather than peroxisomal defects because mice lacking Pex11 β, a peroxisomal protein specifically required for peroxisomal division, die after birth ([@bib47]).

Defects in mitochondrial division and peroxisomal shape in *Drp1^−/−^* mouse embryonic fibroblasts (MEFs)
---------------------------------------------------------------------------------------------------------

To examine mitochondrial shape, we isolated MEFs from E10.5 embryos, immunostained them using anti-Tom20 antibodies, and performed a quantitative analysis ([Fig. 3, A and B](#fig3){ref-type="fig"}). To exclude the possibility that transformation affects the characteristics of MEFs, we used nonimmortalized MEFs in all experiments. In *Drp1*^+/+^ MEFs, mitochondria formed short tubules with occasional branches. In contrast, most *Drp1^−/−^* MEFs contained highly connected, elongated mitochondrial tubules that could be rescued by reexpression of Drp1 ([Fig. 3, A and C](#fig3){ref-type="fig"}). This morphology confirms that Drp1 is required for mitochondrial division. To directly examine mitochondrial division, we used time-lapse microscopy of MEFs expressing matrix-targeted Su9-GFP ([Fig. 3 D](#fig3){ref-type="fig"} and [Videos 1](http://www.jcb.org/cgi/content/full/jcb.200903065/DC1) and [2](http://www.jcb.org/cgi/content/full/jcb.200903065/DC1); [@bib24]). The frequency of mitochondrial division was decreased by 17-fold in *Drp1^−/−^* MEFs compared with *Drp1*^+/+^ MEFs ([Fig. 3 D](#fig3){ref-type="fig"}). However, there appeared to be residual mitochondrial division in *Drp1^−/−^* MEFs ([Fig. 3 E](#fig3){ref-type="fig"}). Time-lapse microscopy also showed that the frequency of extension and retraction of mitochondria tubules with free ends at the edge of mitochondrial networks was increased by approximately threefold in *Drp1^−/−^* MEFs ([Fig. 3, D and F](#fig3){ref-type="fig"}). To analyze the ultrastructure of mitochondria, we used EM and showed that mitochondria were elongated, whereas the inner membrane cristae appeared normal in *Drp1^−/−^* MEFs ([Fig. 3 G](#fig3){ref-type="fig"}). This is in sharp contrast to the dramatic alterations in the cristae membrane structures observed in mitochondria defective in membrane fusion ([@bib53]; [@bib30]; [@bib16]).

![**Characterization of *Drp1^−/−^* MEFs.** (A) MEFs were immunostained with anti-Tom20 antibodies. (B) Quantitation of MEFs with netlike mitochondria (*n* ≥ 3; \>100 cells/experiment). (C) *Drp1^−/−^* MEFs carrying pTracer-EF/Bsd (control; Invitrogen) and pTracer-EF/Bsd-Drp1 were stained with MitoTracker (Invitrogen). (D) Frames from time-lapse confocal microscopy ([Videos 1](http://www.jcb.org/cgi/content/full/jcb.200903065/DC1) and [2](http://www.jcb.org/cgi/content/full/jcb.200903065/DC1)). Arrowheads indicate mitochondrial division, and arrows show extension and retraction of mitochondrial tubules. (E and F) Quantitation of mitochondrial division (E) and extension (F; *n* ≥ 8). (G) EM of mitochondria in MEFs. (H) Peroxisomal morphology. MEFs were immunostained using anti-Pex14 antibodies. (I) EM of peroxisomes in MEFs. Peroxisomes were identified using cytochemical staining for catalase with DAB (arrows). (J) Cell proliferation (*n* ≥ 9). (K) Quantitation of Ki67-positive MEFs (*n* = 6; \>100 cells/experiment). (L) Intracellular ATP levels in control (*Drp1^+/+^* and *Drp1^+/−^*) and *Drp1^−/−^* MEFs (*n* ≥ 6). WT, wild type; KO, knockout. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001. Error bars indicate mean ± SEM.](JCB_200903065R_RGB_Fig3){#fig3}

We examined whether the loss of Drp1 affected the levels of other proteins involved in mitochondrial fusion (Mfn1, Mfn2, and Opa1) and division (Fis1). Levels of Mfn1 and 2, but not Opa1 or Fis1, were decreased by ∼50% in *Drp1^−/−^* MEFs (Fig. S1). It would be interesting to test whether these changes in protein levels alter mitochondrial fusion to compensate for the changes in mitochondrial morphology.

We also examined the shapes of peroxisomes by immunofluorescence microscopy using antibodies to Pex14, a peroxisomal membrane protein ([@bib72]), and EM of peroxisomal catalase staining ([@bib6]). The peroxisomes were relatively round in *Drp1*^+/+^ MEFs, whereas *Drp1^−/−^* MEFs contained elongated peroxisomes ([Fig. 3, H and I](#fig3){ref-type="fig"}; and [Fig. S2](http://www.jcb.org/cgi/content/full/jcb.200903065/DC1)), indicating that defects occurred in peroxisomal division, which supports previous observations ([@bib41]; [@bib62]; [@bib40]). Therefore, our data show that Drp1 controls both mitochondrial and peroxisomal division.

Normal intracellular ATP levels in *Drp1^−/−^* MEFs
---------------------------------------------------

We found that *Drp1^−/−^* MEFs grew slower than *Drp1*^+/+^ MEFs and showed reduced levels of Ki67, a marker for cell proliferation ([Fig. 3, J and K](#fig3){ref-type="fig"}). Consistent with these results, *Drp1^−/−^* embryonic stem (ES) cells have been shown to be defective in normal cell proliferation ([@bib33]). To determine whether the loss of Drp1 affected cellular energy levels, we measured ATP levels in control (*Drp1*^+/+^ and *Drp1*^+/−^) and *Drp1^−/−^* MEFs using a luciferase-based assay. The ATP levels were comparable in these cells ([Fig. 3 L](#fig3){ref-type="fig"}). Therefore, Drp1 was not required for the maintenance of intracellular ATP levels, and the reduced cell proliferation rates of *Drp1^−/−^* MEFs and embryonic lethality in *Drp1^−/−^* mice were not caused by reduced ATP levels. Interestingly, *Drp1*^+/+^ and *Drp1^−/−^* MEFs grew similarly when they were transformed and immortalized using the SV40 large T antigen ([@bib33]). These results suggest that *Drp1^−/−^* MEFs, which are compromised in cell proliferation, can be compensated by alternations in gene expression induced by transformation ([@bib2]).

Roles of Drp1 in apoptosis in vivo and in vitro
-----------------------------------------------

Different roles of Drp1 in apoptosis have been suggested. Some studies showed that Drp1 regulates the mitochondrial outer membrane permeability to release cytochrome *c* independent of mitochondrial division ([@bib25]; [@bib27]; [@bib10]; [@bib35]; [@bib67]). Other studies showed that Drp1 only has a minor role in apoptosis ([@bib57]; [@bib9]; [@bib64]). To determine whether Drp1 regulates apoptosis in vivo, we examined apoptosis in neural tube formation during development ([Fig. 4 A](#fig4){ref-type="fig"}). It has been shown that cells located at the site of closure of neural tubes undergo apoptosis ([@bib42]; [@bib56]). We isolated embryos at E9.5 and 10.5 and immunostained them for activated caspase-3 ([Fig. 4 A](#fig4){ref-type="fig"}). As expected, in *Drp1*^+/+^ embryos, cells located at the site of neural tube closure were positive for activated caspase-3. Conversely, *Drp1^−/−^* embryos showed considerably weaker signals and decreased numbers of caspase-3--positive cells, demonstrating that Drp1 facilitates developmentally regulated apoptosis during neural tube formation.

![**Differential requirements for Drp1 in apoptosis, in vivo, and in vitro.** (A) Whole-mount immunohistochemistry of embryos using antibodies to activated caspase-3. Arrows indicate apoptotic cells at the site of neural tube closure. (B) MEFs were incubated with 1 µM staurosporine for the indicated times, stained with Alexa Fluor 488--annexin V and propidium iodine, and analyzed by flow cytometry (*n* ≥ 3). (C) Quantitation of caspase activity (caspase-3/7) using the fluorogenic substrate DEVD-AFC. MEFs were left untreated (Cont) or treated with the following death stimuli and harvested at the indicated time points: 1 µM staurosporin (Sts; 6 h), 100 µM etoposide (Eto; 24 h), 600 J/m^2^ UV (24 h), and 10 ng/ml TNF-α plus 10 µg/ml cycloheximide (16 h; *n* ≥ 6). (D) Cytochrome *c* release during apoptosis. MEFs were incubated with 100 µM etoposide for 30 h in the presence of Z-VAD-FMK and immunostained using antibodies to cytochrome *c* and Tom20. Arrows indicate cells with released cytochrome *c*. (E) Quantitation of cytochrome *c* release (*n* = 3; \>100 cells/experiment). (F) Quantitation of mitochondrial shape (*n* = 3; \>100 cells/experiment). WT, wild type; KO, knockout. Error bars indicate mean ± SEM.](JCB_200903065_RGB_Fig4){#fig4}

In contrast to the in vivo results, we found that Drp1 is not required for apoptosis in nonimmortalized MEFs in vitro. We incubated MEFs with 1 µM staurosporine for 0, 4, or 12 h and stained them using Alexa Fluor 488--labeled annexin V and propidium iodide. Alexa Fluor 488--annexin V--positive and propidium iodide--negative cells were scored as apoptotic using flow cytometry. The number of apoptotic cells gradually increased and were indistinguishable in *Drp1*^+/+^ and *Drp1^−/−^* MEFs ([Fig. 4 B](#fig4){ref-type="fig"}). Furthermore, we treated MEFs using intrinsic (staurosporine, etoposide, and UV) and extrinsic apoptotic stimuli (TNF-α plus cycloheximide) and examined caspase activity using fluorescent substrate ([Fig. 4 C](#fig4){ref-type="fig"}). The levels of caspase activation were indistinguishable in *Drp1*^+/+^ and *Drp1^−/−^* cells for all stimuli examined. Similarly, during apoptosis, *Drp1*^+/+^ and *Drp1^−/−^* MEF mitochondria divided and fragmented ([Fig. 4, D and F](#fig4){ref-type="fig"}). Comparable numbers of *Drp1*^+/+^ and *Drp1^−/−^* MEFs released cytochrome *c* ([Fig. 4, D and E](#fig4){ref-type="fig"}). The majority of MEFs that released cytochrome *c* contained completely fragmented mitochondria (*Drp1*^+/+^, 89.2 ± 3.9%; *Drp1^−/−^*, 79.6 ± 5.5%; mean ± SEM, *n* = 3). Thus, nonimmortalized MEFs can initiate mitochondrial division and release cytochrome *c* during apoptosis independently of Drp1. Collectively, these results suggest that the requirement of Drp1 in apoptosis likely depends on cell type and physiological apoptotic cue, which accounts for the discrepancies of previous studies ([@bib25]; [@bib27]; [@bib34]; [@bib57]; [@bib1]; [@bib28]; [@bib9]; [@bib10]; [@bib35]; [@bib67]). Supporting our conclusion, a recent study using ES cells and transformed MEFs showed that the effects of Drp1 deficiency on cytochrome *c* release vary depending on the cell type and apoptotic stimulus ([@bib33]).

Drp1 is required for cerebellar development
-------------------------------------------

Mitochondrial division is implicated in many neurodegenerative diseases ([@bib39]), and heterozygous dominant-negative somatic mutation of Drp1 leads to postnatal death with developmental defects in the brain and retina ([@bib71]). To investigate the role of Drp1 in the brain, we used a conditional allele of Drp1 ([Fig. 1 A](#fig1){ref-type="fig"}) and an engrailed 1 (En1)--Cre (En1-Cre) transgenic line, which starts expressing Cre recombinase in the cerebellum and other tissues, including the midbrain and limb buds during development ([@bib38]). By breeding *Drp1^flox/flox^* mice to *Drp1*^*flox*/+^*::En1-Cre* (or *Drp1*^−/+^*::En1-Cre*) mice, we generated mice that carry *Drp1^flox/−^::En1-Cre* and *Drp1^flox/flox^::En1-Cre*, which were phenotypically indistinguishable and are collectively termed En1-Drp1KO hereafter. As controls, we used *Drp1*^*flox*/+^*::En1-Cre* mice, which are phenotypically wild type. En1-Drp1KO mice were born at normal frequencies (23 control and 23 En1-Drp1KO mice in 11 litters) and had body sizes indistinguishable from littermate controls. However, En1-Drp1KO mice died within 36 h of birth. By visual inspection, En1-Drp1KO newborn mice had no milk in their stomachs. When we manually fed control and En1-Drp1KO mice, both mice could drink milk, ruling out the possibility that En1-Drp1KO mice were defective in swallowing.

We found cerebellar development to be defective in En1-Drp1KO mice. We confirmed the expression of En1-Cre in the cerebellum using a reporter strain ([Fig. S3 A](http://www.jcb.org/cgi/content/full/jcb.200903065/DC1); [@bib66]) and the loss of Drp1 by immunostaining ([Fig. 5 A](#fig5){ref-type="fig"}). The cerebellum largely develops postnatally and undergoes morphological changes after birth, including the formation of lobule and migration of Purkinje cells (PCs; [@bib7]; [@bib17]). In control mice, within 1 h of birth (postnatal day \[P\] 0), the cerebellum was round, but the lobule formations were relatively shallow fissures ([Fig. 5 B](#fig5){ref-type="fig"}). In contrast, the cerebella of En1-Drp1KO mice had completely smooth surfaces, and their size was decreased to ∼60% of control cerebella ([Fig. 5, B and C](#fig5){ref-type="fig"}). At the P0.5 stage, control cerebellum had developed further, showing multiple lobules distinguished by deeper fissures. However, in the cerebella of En1-Drp1KO mice, the fissures were barely detectable. To confirm that the cerebellum defect was not caused by starvation, we separated control and En1-Drp1KO mice from their mothers, manually fed them with milk, and obtained similar results.

![**Defects in cerebellar development in En1-Drp1KO mice.** (A) Immunofluorescence of cerebellum (Cb) at P1 using anti-Drp1 antibodies. (B) H&E stains of sagittal sections of cerebella. (C) Area of cerebella in sagittal sections around the median line was determined (*n* = 3). (D and E) Sagittal cerebellar sections were immunostained using antibodies to Ki67 (D) or activated caspase-3 (E). (F) EM of PCs at P0. Arrows indicate mitochondria. Sagittal sections of cerebella are shown. (G) Quantitation of mitochondrial shape and size in PCs. (H) EM of granule cells (GC) in the external granular layer (EGL). Sagittal sections of cerebella are shown. (I) Immunofluorescence of sagittal cerebellar sections around the median line using anti-Car8 antibodies. PCL, PC layer. (D, F, and H) Boxed areas are enlarged in the corresponding panels below. \*, P \< 0.05. Error bars indicate mean ± SEM.](JCB_200903065_RGB_Fig5){#fig5}

The cerebellar developmental defects in En1-Drp1KO mice likely resulted from decreased cell proliferation but not from increased apoptosis. When we immunostained the cerebellum using antibodies against Ki67 for cell proliferation and activated caspase-3 for apoptosis, Ki67 signals were lost in the En1-Drp1KO cerebella ([Fig. 5 D](#fig5){ref-type="fig"}). In contrast, signals for activated caspase-3 were barely detectable in both control and En1-Drp1KO mice ([Fig. 5 E](#fig5){ref-type="fig"}).

Enlarged mitochondria of PCs in En1-Drp1KO cerebella
----------------------------------------------------

When we examined the cerebellum using EM, we found that mitochondrial shape was strikingly altered in PCs but not in granule cells in the En1-Drp1KO mice. In control cerebella, mitochondria had short tubular and small round structures in PCs ([Fig. 5, F and G](#fig5){ref-type="fig"}). In contrast, mitochondria in En1-Drp1KO PCs had large round structures. The number of mitochondria was also considerably decreased in En1-Drp1KO mice. The inner membrane maintained relatively normal cristae morphology. Unlike PCs, granule cells in the external granular layer showed normal mitochondrial morphology in En1-Drp1KO mice ([Fig. 5 H](#fig5){ref-type="fig"}). Our results are consistent with the previous observation that Drp1 is more highly expressed in PCs than granule cells in the cerebellum ([@bib45]) and suggest that mitochondrial shape and dynamics may be regulated by a Drp1-independent mechanism in granule cells.

We then examined PCs in En1-Drp1KO mice using immunofluorescence microscopy with antibodies against Car8, a marker for PCs ([@bib58]). PCs gradually form a monolayer and establish a long axon and highly branched dendrites with a large number of synapses within 2--3 wk of birth ([@bib7]; [@bib17]). In P0 control mice, PCs were slightly elongated, formed thick layers, and lacked dendritic processes ([Fig. 5 I](#fig5){ref-type="fig"}). In P0 En1-Drp1KO mice, the number of PCs was dramatically decreased and formed a discontinuous cell layer ([Fig. 5 I](#fig5){ref-type="fig"}). These results suggest that Drp1 is required for normal proliferation and development of PCs in the cerebellum.

Importantly, the loss of Drp1 led to distinct alterations in mitochondrial morphology in MEFs, PCs, and granule cells. Although it remains to be determined how defects in mitochondrial division resulted in distinct organelle shapes in different cell types, organelle--cytoskeleton interactions may contribute to such differences. Alternatively, lipid compositions may be different in these cell types. Also, specific cell types may use different modes of mitochondrial fusion, which likely create these highly connected or enlarged mitochondria. In support of this idea, Mfn2 is required for cell survival of PCs but not granule cells ([@bib16]). Therefore, we suggest that mitochondrial dynamics is essential for cell type--specific mitochondrial morphogenesis and function.

In this study, using a null allele of *Drp1*, we generated a mammalian model defective in mitochondrial division for the first time and demonstrated that mitochondrial division is required for embryonic development in mice. During development, *Drp1^−/−^* mice showed defects in trophoblast giant cells and cardiomyocytes. Because loss of Drp1 does not severely reduce total intracellular ATP, we suggest that mitochondrial division is important for efficient local ATP delivery. Alternatively, other cellular functions that have been shown to be regulated by mitochondrial division, such as calcium signaling, the control of reactive oxygen species production, apoptosis, and senescence, may be affected. In addition, using a conditional allele of *Drp1*, we showed that Drp1 is required for the development of the cerebellum and mitochondrial morphology in PCs.

Materials and methods
=====================

Generation of knockout mice
---------------------------

All animal work was performed according to guidelines established by the Johns Hopkins University Committee on Animal Care. We inserted a neomycin-resistant marker flanked by flipase (Flp) recombinase target and loxP sites next to exons 3 and 5, which are located in an essential GTPase domain ([Fig. 1 A](#fig1){ref-type="fig"}, Flox-neo). The target region was ∼3.3 kb and included exons 3--5. The targeting vector was transfected into C57BL/6-129/SvEv ES cells by electroporation. G418-resistant colonies were screened by PCR. Targeted ES cells were injected into C57BL/6 blastocysts to create chimeric mice ([@bib69]). To create the null Drp1 allele, we crossed Flox-neo mice to a transgenic strain that expresses Cre recombinase from the EIIa promoter ([@bib44]) and confirmed loxP recombination by PCR ([Fig. 1, A \[Null\] and B](#fig1){ref-type="fig"}). In addition, upon loxP recombination, a stop codon was generated immediately after exon 2 as a result of a frame shift. To generate the conditional allele, Flox-neo mice were crossed to a transgenic strain that ubiquitously expresses Flp recombinase ([@bib23]) and confirmed Flp recombinase target recombination by PCR ([Fig. 1, A \[Floxed\] and B](#fig1){ref-type="fig"}). We bred these strains to a wild-type strain and isolated mice heterozygous for the null or conditional allele but not Cre or Flp recombinase. To distinguish *Drp1^+/+^*, *Drp1^+/−^*, and *Drp1^−/−^* by PCR, the PCR primers D1 (5′-CACTGAGAGCTCTATATGTAGGC-3′), D3 (5′-ACCAAAGTAAGGAATAGCTGTTG-3′), and D5 (5′-GAGTACCTAAAGTGGACAAGAGGTCC-3′) were used. For floxed alleles, D3 and D6 (5′-ATGCGCTGATAATACTATCAACC-3′) were used.

Histology
---------

After timed breeding and confirmation of vaginal plugs, embryos were isolated at E9.5--11.5. For histological analysis of the heart, embryos were fixed in PBS containing 4% paraformaldehyde overnight and embedded in paraffin at the Johns Hopkins University reference histology facility. Paraffin sections were stained using hematoxylin and eosin (H&E). H&E-stained sections were viewed on an upright microscope (BX51; Olympus) equipped with 4× 0.16 NA and 10× 0.3 NA objectives (UIS2; Olympus), and a color camera (DP-70; Olympus) was used.

Placenta were dissected from embryos, fixed, and embedded in paraffin. Paraffin sections were stained with 1 µg/ml DAPI. Sections were viewed on a motorized upright microscope (BX61; Olympus) equipped with a charge-coupled device (CCD) camera (CoolSnap HQ; Roper Scientific).

For whole-mount immunohistochemistry, embryos were fixed in 4% paraformaldehyde in PBS overnight at 4°C ([@bib50]). After washes in PBS, samples were incubated in 80% methanol containing 6% H~2~O~2~ for 1 h at room temperature. Samples were immersed twice in 100% methanol for 10 min and in 3 ml 1:1 methanol/DMSO. 0.75 ml 10% Triton X-100 was added to the methanol/DMSO solution. After 15--30-min incubation, samples were washed three times in TST (100 mM Tris-HCl, pH 7.8, 0.1% Triton X-100, and 154 mM NaCl) and blocked in 5% skim milk in TST overnight at 4°C. Embryos were stained with antibodies against cleaved caspase-3 (1:200; clone 5A1; Cell Signaling Technology) and PECAM/CD31 (1:10; clone MEC13.3; BD) for 24 h at 4°C. After several washes, samples were incubated with appropriate secondary antibodies conjugated with horseradish peroxidase (1:100; GE Healthcare) overnight. Samples were incubated in TST containing 250 µg/ml 3,3′-diaminobenzidine for ∼30 min on ice and 250 µg/ml 3,3′-diaminobenzidine containing 0.003% H~2~O~2~ for 15--30 min on ice. After extensive washes in TST, samples were postfixed in 4% paraformaldehyde in PBS at room temperature for 20 min. Samples were viewed using a stereo microscope (SZX12; Olympus) equipped with a color camera (DP-70; Olympus).

For immunofluorescence of the cerebellum, newborn pups were fixed by perfusing 4% paraformaldehyde in PBS. After removing the skin, the head was further fixed for 2--3 h. The brain was dissected and fixed overnight at 4°C. After embedding in paraffin, sections were cut, deparaffinized, washed in PBS, and blocked in MOM-blocking reagent according to the manufacturer\'s protocol (Vector Laboratories). Samples were incubated with anti-Drp1 antibodies (1:100; clone 8; BD) at room temperature for 2 h and then with Alexa Fluor 488 anti--mouse IgG (1:400). For immunofluorescence of PCs, paraffin sections were stained with anti-Car8 antibodies (1:400; [@bib58]) followed by Alexa Fluor 488--labeled secondary antibodies (1:400; Invitrogen). Samples were observed on a motorized upright microscope (BX61; Olympus).

Immunoblotting of embryos
-------------------------

Proteins were extracted from embryos in RIPA buffer and analyzed by immunoblotting using antibodies against Drp1 (clone 8; BD), the mitochondrial protein Tim23 (clone 32; BD), and the ER protein PGRMC1 ([@bib79]).

Isolation of MEFs and cardiomyocytes
------------------------------------

After removing brain and heart, E10.5 embryos were digested with 200 µl 0.05% trypsin 0.02% EDTA at 37°C for 10 min. After addition of 800 µl Iscove\'s modified Dulbecco\'s medium (Invitrogen) containing 10% fetal bovine serum (Invitrogen) and 100 µg/ml primocin (Invitrogen), MEFs were dispersed by pipetting ([@bib70]). After washes, MEFs were cultured in Iscove\'s modified Dulbecco\'s medium containing 10% fetal bovine serum and 100 µg/ml primocin at 37°C in a humidified atmosphere of 5% CO~2~ ([@bib70]). In all of the experiments, MEFs of at least three independent preparations per genotype were used without transformation or immortalization.

For isolation of cardiomyocytes, hearts were digested with 200 µl 0.05% trypsin 0.02% EDTA at 37°C for 20 min ([@bib51]). After washes, cells were incubated in Iscove\'s modified Dulbecco\'s medium containing 10% fetal bovine serum and 100 µg/ml primocin at 37°C in a humidified atmosphere of 5% CO~2~ for 2 h. Culture media containing unattached cardiomyocytes were collected. 6 d after isolation, cardiomyocytes were observed at 37°C using a microscope (Axio Observer Z1; Carl Zeiss, Inc.) equipped with an environmentally controlled enclosure to monitor CO~2~ levels, temperature, and humidity (Precision Plastic).

Observation of organelles in MEFs
---------------------------------

For visualization of mitochondria, MEFs were fixed in prewarmed PBS containing 4% paraformaldehyde for 30 min and permeabilized with 0.1% Triton X-100 in PBS for 10 min. After blocking in 0.5% BSA, cells were incubated with anti-Tom20 antibodies (1:100; Santa Cruz Biotechnology, Inc.) followed by Alexa Fluor 488--labeled secondary antibodies (1:2,000; Invitrogen). For time-lapse observations, MEFs were grown in 8-well chambered coverglass (Laboratory-Tek II; Thermo Fisher Scientific), transfected with a plasmid carrying Su9-GFP ([@bib24]) using GeneJuice (EMD), and observed using a custom-assembled microscope comprised of a fully automated microscope (Axio Observer Z1), a spinning-disc confocal (CSU22; Yokogawa), and a camera (Cascade II 512b; Roper Scientific) with an environmentally controlled enclosure to monitor CO~2~ levels, temperature, and humidity.

For observation of peroxisomes, MEFs were grown in 8-well chamber slides (Laboratory-Tek II), fixed in prewarmed PBS containing 4% paraformaldehyde for 30 min, and permeabilized with 0.1% Triton X-100 in PBS for 10 min. After blocking in 0.5% BSA, cells were incubated for 3 h with anti-Pex14 antibodies (1:200) followed by Alexa Fluor 488--labeled secondary antibodies (1:2,000; Invitrogen). Cells were viewed on a motorized upright microscope (BX61) equipped with a 40× 0.75 NA objective (UIS2) and a CCD camera (CoolSnap HQ). SlideBook (3i), QuickTime 7 (Apple, Inc.), Photoshop (Adobe), and ImageJ (National Institutes of Health) software were used to analyze images.

MEF proliferation
-----------------

*Drp1^+/+^* and *Drp1^−/−^* MEFs were isolated, cultured for 5 d, and plated at a density of 2--4 × 10^4^ cells/well in 24-well dishes on day 0. Cell numbers were counted at the indicated time points and normalized relative to day 1.

ATP measurements
----------------

MEFs were collected by centrifugation, incubated with 10 µl 5% TCA, and lysed in 90 µl 1% Triton X-100 and 100 mM Tris-actate, pH 8.0, according to the manufacturer\'s instructions (Enliten ATP assay system; Promega). Luminescence was measured using a Fluostar Optima (BMG Labtech).

Apoptosis in MEFs
-----------------

MEFs were used in all of the apoptosis assays within three weeks after isolation. MEFs were incubated with 1 µM staurosporine for 0, 4, or 12 h, collected, and stained with Alexa Fluor 488--annexin V and propidium iodine according to the manufacturer\'s instructions (Invitrogen). Cells were analyzed using FACScan (BD). To measure caspase activity, MEFs were incubated with various apoptotic stimuli, including 1 µM staurosporine for 6 h, 100 µM etoposide for 24 h, 600 J/m^2^ UV for 24 h, and 10 ng/ml TNF-α plus 10 µg/ml cycloheximide for 16 h, lysed, and incubated with a fluorogenic substrate according to the manufacturer\'s instructions (Apo-ONE homogeneous caspase-3/7 assay kit; Promega). Fluorescence was measured using Fluostar Optima.

For analysis of cytochrome *c* release, MEFs were preincubated with 40 µM Z-VAD-FMK for 1 h, treated with 1 µM staurosporine for 3 and 6 h or100 µM etoposide for 20, 24, 30, and 42 h in the presence of 40 µM Z-VAD-FMK, fixed in prewarmed PBS containing 4% paraformaldehyde for 30 min, and permeabilized with 0.1% Triton X-100 in PBS for 10 min. After blocking in 0.5% BSA, cells were incubated with antibodies against cytochrome *c* (1:200; clone 6H2.B4; BD) and Tom20 (1:100; Santa Cruz Biotechnology, Inc.) overnight at 4°C followed by appropriate secondary antibodies.

Immunofluorescence for Ki67 and activated caspase-3
---------------------------------------------------

MEFs were fixed in prewarmed PBS containing 4% paraformaldehyde for 30 min and permeabilized with 0.1% Triton X-100 in PBS for 10 min. After blocking in 0.5% BSA, cells were incubated with antibodies against Ki67 (1:100; AB15580; Abcam) followed by Alexa Fluor 594--labeled secondary antibodies.

Sagittal sections of control and En1-Drp1KO cerebella were immunostained using antibodies to Ki67 (1:250; Abcam) or activated caspase-3 (1:200; clone 5A1; Cell Signaling Technology) as a marker for apoptosis and Alexa Fluor 488--labeled secondary antibodies. Samples were viewed on a microscope (BX61) equipped with a 40× 0.75 NA objective (UIS2) and a CCD camera (CoolSnap HQ) for Ki67 and on a confocal microscope (510 Meta; Carl Zeiss, Inc.) for activated caspase-3.

EM
--

The heads of pups were dissected and fixed in 3% paraformaldehyde, 1.5% glutaraldehyde, 2.5% sucrose, and 100 mM cacodylate, pH 7.4, overnight. Brains were dissected and further fixed for 2 d. After washes, samples were postfixed in 2.7% OsO~4~ and 167 mM cacodylate, pH 7.4, for 1 h on ice. After washes in water, samples were incubated in 2% uranyl acetate for 30 min. After dehydration using 50, 70, 90, and 100% ethanol and 100% propylene oxide, samples were embedded in epon resin (Ted Pella, Inc.). Ultrathin sections were obtained using a Reichert-Jung ultracut E, stained with 2% uranyl acetate and lead citrate, and viewed on a transmission electron microscope (H-7600; Hitachi) equipped with a dual CCD camera (Advanced Microscopy Techniques). ImageJ software was used to measure the length and size of mitochondria.

MEFs were fixed in prewarmed 2% glutaraldehyde, 2.5% sucrose, 3 mM CaCl~2~, and 100 mM Hepes, pH 7.4, for 1 h. After washes, MEFs were postfixed using reduced OsO~4~ (1% OsO~4~, 10 mg/ml potassium ferrocyanide, 1.25% sucrose, and 100 mM cacodylate, pH 7.4) for 1 h on ice. After washes in water, cells were incubated in 2% uranyl acetate for 30 min. After dehydration using 50, 70, 90, and 100% ethanol, samples were embedded in epon resin. For cytochemical staining of catalase, MEFs were fixed (4% paraformaldehyde, 0.05% glutaraldehyde, 2.5% sucrose, 3 mM CaCl~2~, and 100 mM Hepes, pH 7.4) for 1 h. After washes, MEFs were incubated in 2 mg/ml DAB, 0.15% H~2~O~2~, and 100 mM glycine NaOH, pH 10.5, at 37°C for 1 h ([@bib6]). Samples were postfixed, dehydrated, and embedded as described in the previous paragraph.

Statistical analysis
--------------------

All values are mean ± SEM. Results were statistically analyzed using *t* test (\*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001).

Online supplemental material
----------------------------

Fig. S1 shows the characterization of *Drp1^+/+^* and *Drp1^+/−^* mice and *Drp1^+/+^* and *Drp1^−/−^* MEFs using immunoblot analysis. Fig. S2 shows *Drp1^+/+^* and *Drp1^−/−^* MEFs immunostained with anti-Pex14 antibodies. Fig. S3 shows that En1-Cre is expressed in the whole cerebellum and H&E stains of the sections adjacent to those shown in [Fig. 5 D](#fig5){ref-type="fig"}. Video 1 shows the characterization of *Drp1^+/+^* MEFs expressing matrix-targeted Su9-GFP using time-lapse confocal microscopy. Video 2 shows the characterization of *Drp1^−/−^* MEFs expressing matrix-targeted Su9-GFP using time-lapse confocal microscopy. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.200903065/DC1>.
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